Polymeric nanocarrier systems for photodynamic therapy

Biomaterials Research

Volumn 18, Issue 1, 2014, Pages

  Li, Li ^a   Huh, Kang Moo ^a  

^a Chungnam National University   (South Korea)

Author keywords

Conjugates; Drug delivery; Nanocarrier; Photodynamic therapy; Photosensitizer; Polymer

Indexed keywords

EID: 85030973397     PISSN: None     EISSN: 20557124     Source Type: Journal    
DOI: 10.1186/2055-7124-18-19     Document Type: Review

References (88)

1. Hamblin MR, Mröz P: Advances in Photodynamic Therapy: Basic, Translational, and Clinical. Boston, Mass: Artech House; 2008.
2. Juarranz A, Jaen P, Sanz-Rodriguez F, Cuevas J, Gonzalez S: Photodynamic therapy of cancer. Basic principles and applications. Clin Transl Oncol Off Publ Federation Spanish Oncol Soc National Cancer Institute Mexico 2008, 10:148-154.
3. MacDonald IJ, Dougherty TJ: Basic principles of photodynamic therapy. J Porphyr Phthalocya 2001, 5:105-129.
4. Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J, Peng Q: Photodynamic therapy. J Natl Cancer Inst 1998, 90:889-905.
5. Zimcik P, Miletin M: Photodynamic therapy as a new prospective method for cancer treatment. I. History, basic principles. Ceska Slovenska Farmacie Casopis Ceske Farmaceuticke Spolecnosti Slovenske Farmaceuticke Spolecnosti 2004, 53:219-224.
6. Wilson BC: Photodynamic therapy for cancer: principles. Can J Gastroenterol J Can Gastroenterol 2002, 16:393-396.
7. Dolmans DE, Fukumura D, Jain RK: Photodynamic therapy for cancer. Nat Rev Cancer 2003, 3:380-387.
8. Sutedja TG, Postmus PE: Photodynamic therapy in lung cancer. A review. J Photochem Photobiol B 1996, 36:199-204.
9. Senior K: Photodynamic therapy for bladder cancer. Lancet oncol 2005, 6:546.
10. Biel MA: Photodynamic therapy of head and neck cancers. Methods Mol Biol 2010, 635:281-293.
11. Goff BA, Blake J, Bamberg MP, Hasan T: Treatment of ovarian cancer with photodynamic therapy and immunoconjugates in a murine ovarian cancer model. Br J Cancer 1996, 74:1194-1198.
12. Muschter R: Photodynamic therapy: a new approach to prostate cancer. Current Urol Reports 2003, 4:221-228.
13. Roberts DJ, Cairnduff F: Photodynamic therapy of primary skin cancer: a review. Br J Plast Surg 1995, 48:360-370.
14. Guleng GE, Helsing P: Photodynamic therapy for basal cell carcinomas in organ-transplant recipients. Clin Exp Dermatol 2012, 37:367-369.
15. Konan YN, Gurny R, Allemann E: State of the art in the delivery of photosensitizers for photodynamic therapy. J Photoch Photobio B 2002, 66:89-106.
16. Nowis D, Makowski M, Stoklosa T, Legat M, Issat T, Golab J: Direct tumor damage mechanisms of photodynamic therapy. Acta Biochim Pol 2005, 52:339-352.
17. Milla Sanabria L, Rodriguez ME, Cogno IS, Rumie Vittar NB, Pansa MF, Lamberti MJ, Rivarola VA: Direct and indirect photodynamic therapy effects on the cellular and molecular components of the tumor microenvironment. Biochim Biophys Acta 1835, 2013:36-45.
18. Krammer B: Vascular effects of photodynamic therapy. Anticancer Res 2001, 21:4271-4277.
19. Vancikova Z: Principles of the photodynamic therapy and its impact on the immune system. Sb Lek 1998, 99:1-11.
20. Nowis D, Stoklosa T, Legat M, Issat T, Jakobisiak M, Golab J: The influence of photodynamic therapy on the immune response. Photodiagnosis Photodyn Ther 2005, 2:283-298.
21. Detty MR, Gibson SL, Wagner SJ: Current clinical and preclinical photosensitizers for use in photodynamic therapy. J Med Chem 2004, 47:3897-3915.
22. O'Connor AE, Gallagher WM, Byrne AT: Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy. Photochem Photobiol 2009, 85:1053-1074.
23. Ethirajan M, Chen Y, Joshi P, Pandey RK: The role of porphyrin chemistry in tumor imaging and photodynamic therapy. Chem Soc Rev 2011, 40:340-362.
24. Daicoviciu D, Filip A, Ion RM, Clichici S, Decea N, Muresan A: Oxidative photodamage induced by photodynamic therapy with methoxyphenyl porphyrin derivatives in tumour-bearing rats. Folia Biol 2011, 57:12-19.
25. Pandey RK, Bellnier DA, Smith KM, Dougherty TJ: Chlorin and porphyrin derivatives as potential photosensitizers in photodynamic therapy. Photochem Photobiol 1991, 53:65-72.
26. Spikes JD: Phthalocyanines as photosensitizers in biological systems and for the photodynamic therapy of tumors. Photochem Photobiol 1986, 43:691-699.
27. Moeno S, Krause RW, Ermilov EA, Kuzyniak W, Hopfner M: Synthesis and characterization of novel zinc phthalocyanines as potential photosensitizers for photodynamic therapy of cancers. Photochem Photobiol Sci 2014, 13:963-970.
28. Durmus M, Ahsen V: Water-soluble cationic gallium(III) and indium(III) phthalocyanines for photodynamic therapy. J Inorg Biochem 2010, 104:297-309.
29. Kreimer-Birnbaum M: Modified porphyrins, chlorins, phthalocyanines, and purpurins: second-generation photosensitizers for photodynamic therapy. Semin Hematol 1989, 26:157-173.
30. O'Neal WG, Roberts WP, Ghosh I, Wang H, Jacobi PA: Studies in chlorin chemistry. 3. A practical synthesis of c, d-ring symmetric chlorins of potential utility in photodynamic therapy. J Org Chem 2006, 71:3472-3480.
31. Vrouenraets MB, Visser GW, Snow GB, van Dongen GA: Basic principles, applications in oncology and improved selectivity of photodynamic therapy. Anticancer Res 2003, 23:505-522.
32. Liebmann J, Cook JA, Mitchell JB: Cremophor EL, solvent for paclitaxel, and toxicity. Lancet 1993, 342:1428.
33. Gelderblom H, Verweij J, Nooter K, Sparreboom A: Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. Eur J Cancer 2001, 37:1590-1598.
34. Derycke AS, de Witte PA: Liposomes for photodynamic therapy. Adv Drug Deliv Rev 2004, 56:17-30.
35. Broekgaarden M, de Kroon AI, Gulik TM, Heger M: Development and in vitro proof-of-concept of interstitially targeted zinc- phthalocyanine liposomes for photodynamic therapy. Curr Med Chem 2013, 21:377-391.
36. Bovis MJ, Woodhams JH, Loizidou M, Scheglmann D, Bown SG, Macrobert AJ: Improved in vivo delivery of m-THPC via pegylated liposomes for use in photodynamic therapy. J Control Release 2012, 157:196-205.
37. Ricci-Junior E, Marchetti JM: Preparation, characterization, photocytotoxicity assay of PLGA nanoparticles containing zinc (II) phthalocyanine for photodynamic therapy use. J Microencapsul 2006, 23:523-538.
38. Ricci-Junior E, Marchetti JM: Zinc(II) phthalocyanine loaded PLGA nanoparticles for photodynamic therapy use. Int J Pharm 2006, 310:187-195.
39. Chatterjee DK, Fong LS, Zhang Y: Nanoparticles in photodynamic therapy: an emerging paradigm. Adv Drug Deliv Rev 2008, 60:1627-1637.
40. Lee YE, Kopelman R: Polymeric nanoparticles for photodynamic therapy. Methods Mol Biol 2011, 726:151-178.
41. Chung CW, Chung KD, Jeong YI, Kang DH: 5-aminolevulinic acid-incorporated nanoparticles of methoxy poly(ethylene glycol)-chitosan copolymer for photodynamic therapy. Int J Nanomedicine 2013, 8:809-819.
42. Taillefer J, Brasseur N, van Lier JE, Lenaerts V, Le Garrec D, Leroux JC: In-vitro and in-vivo evaluation of pH-responsive polymeric micelles in a photo- dynamic cancer therapy model. J Pharmacy Pharmacol 2001, 53:155-166.
43. Gibot L, Lemelle A, Till U, Moukarzel B, Mingotaud AF, Pimienta V, Saint-Aguet P, Rols MP, Gaucher M, Violleau F, Chassenieux C, Vicendo P: Polymeric micelles encapsulating photosensitizer: structure/photodynamic therapy efficiency relation. Biomacromolecules 2014, 15:1443-1455.
44. Koo H, Lee H, Lee S, Min KH, Kim MS, Lee DS, Choi Y, Kwon IC, Kim K, Jeong SY: In vivo tumor diagnosis and photodynamic therapy via tumoral pH-responsive polymeric micelles. Chem Commun (Camb) 2010, 46:5668-5670.
45. van Nostrum CF: Polymeric micelles to deliver photosensitizers for photodynamic therapy. Adv Drug Deliv Rev 2004, 56:9-16.
46. Maeda H: The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv Enzyme Regul 2001, 41:189-207.
47. Nehoff H, Parayath NN, Domanovitch L, Taurin S, Greish K: Nanomedicine for drug targeting: strategies beyond the enhanced permeability and retention effect. Int J Nanomedicine 2014, 9:2539-2555.
48. Li F, Bae BC, Na K: Acetylated hyaluronic acid/photosensitizer conjugate for the preparation of nanogels with controllable phototoxicity: synthesis, characterization, autophotoquenching properties, and in vitro phototoxicity against HeLa cells. Bioconjug Chem 2010, 21:1312-1320.
49. Bae BC, Na K: Self-quenching polysaccharide-based nanogels of pullulan/ folate-photosensitizer conjugates for photodynamic therapy. Biomaterials 2010, 31:6325-6335.
50. Li L, Bae BC, Tran TH, Yoon KH, Na K, Huh KM: Self-quenchable biofunctional nanoparticles of heparin-folate-photosensitizer conjugates for photodynamic therapy. Carbohyd Polym 2011, 86:708-715.
51. Oh IH, Min HS, Li L, Tran TH, Lee YK, Kwon IC, Choi K, Kim K, Huh KM: Cancer cell-specific photoactivity of pheophorbide a-glycol chitosan nanoparticles for photodynamic therapy in tumor-bearing mice. Biomaterials 2013, 34:6454-6463.
52. Kim WL, Cho H, Li L, Kang HC, Huh KM: Biarmed poly(ethylene glycol)- (pheophorbide a)2 conjugate as a bioactivatable delivery carrier for photodynamic therapy. Biomacromolecules 2014, 15:2224-2234.
53. Park W, Park SJ, Na K: The controlled photoactivity of nanoparticles derived from ionic interactions between a water soluble polymeric photosensitizer and polysaccharide quencher. Biomaterials 2011, 32:8261-8270.
54. Li L, Nurunnabi M, Nafiujjaman M, Lee YK, Huh KM: GSH-mediated photoactivity of pheophorbide a-conjugated heparin/gold nanoparticle for photodynamic therapy. J Control Release 2013, 171:241-250.
55. Li L, Md N, Md N, Jeong YY, Lee YK, Huh KM: A photosensitizer-conjugated magnetic iron oxide/gold hybrid nanoparticle as an activatable platform for photodynamic cancer therapy. J Mater Chem B 2014, 2:2929-2937.
56. Matsumura Y, Maeda H: A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 1986, 46:6387-6392.
57. Maeda H, Matsumura Y: Tumoritropic and lymphotropic principles of macromolecular drugs. Crit Rev Ther Drug Carrier Syst 1989, 6:193-210.
58. Ben-Dror S, Bronshtein I, Wiehe A, Roder B, Senge MO, Ehrenberg B: On the correlation between hydrophobicity, liposome binding and cellular uptake of porphyrin sensitizers. Photochem Photobiol 2006, 82:695-701.
59. Love WG, Duk S, Biolo R, Jori G, Taylor PW: Liposome-mediated delivery of photosensitizers: localization of zinc (II)-phthalocyanine within implanted tumors after intravenous administration. Photochem Photobiol 1996, 63:656-661.
60. Casas A, Batlle A: Aminolevulinic acid derivatives and liposome delivery as strategies for improving 5-aminolevulinic acid-mediated photodynamic therapy. Curr Med Chem 2006, 13:1157-1168.
61. Richter AM, Waterfield E, Jain AK, Canaan AJ, Allison BA, Levy JG: Liposomal delivery of a photosensitizer, benzoporphyrin derivative monoacid ring A (BPD), to tumor tissue in a mouse tumor model. Photochem Photobiol 1993, 57:1000-1006.
62. Namiki Y, Namiki T, Date M, Yanagihara K, Yashiro M, Takahashi H: Enhanced photodynamic antitumor effect on gastric cancer by a novel photosensitive stealth liposome. Pharmacol Res Off J Ital Pharmacol Soc 2004, 50:65-76.
63. Sibani SA, McCarron PA, Woolfson AD, Donnelly RF: Photosensitiser delivery for photodynamic therapy. Part 2: systemic carrier platforms. Expert Opin Drug Deliv 2008, 5:1241-1254.
64. Chan JM, Valencia PM, Zhang L, Langer R, Farokhzad OC: Polymeric nanoparticles for drug delivery. Methods Mol Biol 2010, 624:163-175.
65. Veronese FM, Pasut G: PEGylation, successful approach to drug delivery. Drug Discov Today 2005, 10:1451-1458.
66. Jain A, Jain SK: PEGylation: an approach for drug delivery. A review. Crit Rev Ther Drug Carrier Syst 2008, 25:403-447.
67. Kumari A, Yadav SK, Yadav SC: Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B: Biointerfaces 2010, 75:1-18.
68. Allemann E, Brasseur N, Benrezzak O, Rousseau J, Kudrevich SV, Boyle RW, Leroux JC, Gurny R, Van Lier JE: PEG-coated poly(lactic acid) nanoparticles for the delivery of hexadecafluoro zinc phthalocyanine to EMT-6 mouse mammary tumours. J Pharmacy Pharmacol 1995, 47:382-387.
69. Konan YN, Berton M, Gurny R, Allemann E: Enhanced photodynamic activity of meso-tetra(4-hydroxyphenyl)porphyrin by incorporation into sub-200 nm nanoparticles. Eur J Pharm Sci 2003, 18:241-249.
70. KonanYN,CernyR,FavetJ,BertonM,GurnyR,AllemannE: Preparation and characterization of sterile sub-200 nm meso-tetra(4-hydroxylphenyl)porphy- rin-loaded nanoparticles for photodynamic therapy. Eur J Pharm Biopharm Off J Arbeitsgemeinschaft Pharm Verfahrenstechnik eV 2003, 55:115-124.
71. Aliabadi HM, Lavasanifar A: Polymeric micelles for drug delivery. Expert Opin Drug Deliv 2006, 3:139-162.
72. Nishiyama N, Kataoka K: Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. Pharmacol Ther 2006, 112:630-648.
73. Li B, Moriyama EH, Li F, Jarvi MT, Allen C, Wilson BC: Diblock copolymer micelles deliver hydrophobic protoporphyrin IX for photodynamic therapy. Photochem Photobiol 2007, 83:1505-1512.
74. Shieh MJ, Peng CL, Chiang WL, Wang CH, Hsu CY, Wang SJ, Lai PS: Reduced skin photosensitivity with meta-tetra(hydroxyphenyl)chlorin- loaded micelles based on a poly(2-ethyl-2-oxazoline)-b-poly(d, l-lactide) diblock copolymer in vivo. Mol Pharm 2010, 7:1244-1253.
75. Knop K, Mingotaud AF, El-Akra N, Violleau F, Souchard JP: Monomeric pheophorbide(a)-containing poly(ethyleneglycol-b-epsilon-caprolactone) micelles for photodynamic therapy. Photochem Photobiol Sci 2009, 8:396-404.
76. Li L, Cho H, Yoon KH, Kang HC, Huh KM: Antioxidant-photosensitizer dual-loaded polymeric micelles with controllable production of reactive oxygen species. Int J Pharm 2014, 471:339-348.
77. Muthiah M, Park SH, Nurunnabi M, Lee J, Lee YK, Park H, Lee BI, Min JJ, Park IK: Intracellular delivery and activation of the genetically encoded photosensitizer Killer Red by quantum dots encapsulated in polymeric micelles. Colloid Surface B Biointerfaces 2014, 116:284-294.
78. Bulina ME, Chudakov DM, Britanova OV, Yanushevich YG, Staroverov DB, Chepurnykh TV, Merzlyak EM, Shkrob MA, Lukyanov S, Lukyanov KA: A genetically encoded photosensitizer. Nat Biotechnol 2006, 24:95-99.
79. Liao ZX, Li YC, Lu HM, Sung HW: A genetically-encoded KillerRed protein as an intrinsically generated photosensitizer for photodynamic therapy. Biomaterials 2014, 35:500-508.
80. Pletnev S, Gurskaya NG, Pletneva NV, Lukyanov KA, Chudakov DM, Martynov VI, Popov VO, Kovalchuk MV, Wlodawer A, Dauter Z, Pletnev V: Structural basis for phototoxicity of the genetically encoded photosensitizer KillerRed. J Biol Chem 2009, 284:32028-32039.
81. Ryumina AP, Serebrovskaya EO, Shirmanova MV, Snopova LB, Kuznetsova MM, Turchin IV, Ignatova NI, Klementieva NV, Fradkov AF, Shakhov BE, Zagaynova EV, Lukyanov KA, Lukyanov SA: Flavoprotein miniSOG as a genetically encoded photosensitizer for cancer cells. Biochim Biophys Acta 1830, 2013:5059-5067.
82. Verhille M, Couleaud P, Vanderesse R, Brault D, Barberi-Heyob M, Frochot C: Modulation of photosensitization processes for an improved targeted photodynamic therapy. Curr Med Chem 2010, 17:3925-3943.
83. Lovell JF, Liu TWB, Chen J, Zheng G: Activatable Photosensitizers for Imaging and Therapy. Chem Rev 2010, 110:2839-2857.
84. Bugaj AM: Targeted photodynamic therapya promising strategy of tumor treatment. Photochem Photobiol Sci 2011, 10:1097-1109.
85. McCarthy JR, Weissleder R: Model systems for fluorescence and singlet oxygen quenching by metalloporphyrins. ChemMedChem 2007, 2:360-365.
86. Lovell JF, Chen J, Jarvi MT, Cao WG, Allen AD, Liu Y, Tidwell TT, Wilson BC, Zheng G: FRET quenching of photosensitizer singlet oxygen generation. J Phys Chem B 2009, 113:3203-3211.
87. Lee SJ, Koo H, Lee DE, Min S, Lee S, Chen X, Choi Y, Leary JF, Park K, Jeong SY, Kwon IC, Kim K, Choi K: Tumor-homing photosensitizer-conjugated glycol chitosan nanoparticles for synchronous photodynamic imaging and therapy based on cellular on/off system. Biomaterials 2011, 32:4021-4029.
88. Gamcsik MP, Kasibhatla MS, Teeter SD, Colvin OM: Glutathione levels in human tumors. Biomarkers 2012, 17:671-691.